Clinical trial registry record

Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 4, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06629272
Last registry update
September 4, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
University of Michigan
Enrollment
900
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · HEALTH SERVICES RESEARCH · DOUBLE
Evidence population
Human clinical study registration
Participants
900
Population
ALL · 65 Years
Duration
2024-12-02 to 2028-08-31
Intervention
D-THIO (Deprescribing Thyroid Hormone In Older Adults); Enhanced usual care
Comparator
Enhanced usual care
Outcomes measured
Thyroid hormone deprescribing by providers — 6 months post-enrollment; Reduction of thyroid hormone overtreatment, measured as proportion of patients who had their TSH normalized. — 6 months…; Provider-reported knowledge — 6-12 months post-enrollment; Provider-reported intent to deprescribe — 6-12 months post-enrollment; Provider-reported self-efficacy — 6-12 months post-enrollment; Patient-reported discussion of deprescribing with provider — 3-6 months post-enrollment; Patient-reported knowledge — 3-6 months post-enrollment; Patient-reported attitudes towards deprescribing — 3-6 months post-enrollment; Patient-reported beliefs about medicines — 3-6 months post-enrollment
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Deprescribing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

deprescribing
Read the original source →Export JSON